Cargando…

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World

PURPOSE: To compare survival in different strategies, preoperative systemic treatment versus upfront surgery, in HER2-positive early breast cancer patients in the real world. METHODS: According to the actual upfront treatment, eligible patients from 2012 to 2015 were classified as preoperative syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xingfei, Wang, Chen, Zheng, Yabing, Miao, Beibei, Hu, Jiejie, Shao, Xiying, Sheng, Liming, Lin, Juan, Ding, Yuqin, Xuan, Haojun, Ding, Yingying, Gong, Lijie, Feng, Weiliang, Qin, Chengdong, Chen, Daobao, Yu, Yang, Yang, Hongjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356668/ https://www.ncbi.nlm.nih.gov/pubmed/34395277 http://dx.doi.org/10.3389/fonc.2021.704842

Ejemplares similares

LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis
por: Li, Yongfeng, et al.
Publicado: (2021)

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
por: Ding, Yuqin, et al.
Publicado: (2020)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China
por: Ding, Yuqin, et al.
Publicado: (2019)

Construction and validation of prognostic nomogram for metaplastic breast cancer
por: Li, Yongfeng, et al.
Publicado: (2022)

Survival Advantage of Upfront Surgery for Pancreatic Head Cancer Without Preoperative Biliary Drainage
por: Pande, Rupaly, et al.
Publicado: (2020)

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
por: Ding, Yuqin, et al.
Publicado: (2023)

PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR ADVANCED GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
por: Hong, Stefany, et al.
Publicado: (2023)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients
por: Ding, Yuqin, et al.
Publicado: (2020)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases
por: Shin, Sang Joon, et al.
Publicado: (2011)

Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
por: Yu, Guopan, et al.
Publicado: (2017)

Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer
por: Xiping, Zhang, et al.
Publicado: (2017)

EXPERIMENTAL STUDY OF CHEMOTHERAPY RELATED LEUKOCYTOPENIA TREATED BY VARIOUS PEROAL LEUCOCYTE INCREASING DRUGS
por: Xiping, Zhang, et al.
Publicado: (2016)

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)

Surgery for Crohn’s disease: upfront or last resort?
por: Ahmed Ali, U, et al.
Publicado: (2022)

Complete Radiologic Response of Bulky Cerebral Metastases From Newly Diagnosed HER2-Positive Breast Cancer to Upfront Trastuzumab-Based Chemotherapy
por: Brungs, Daniel, et al.
Publicado: (2013)

Introducing Upfront Money Can Decrease Discounting in Intertemporal Choices with Losses
por: Jiang, Cheng-Ming, et al.
Publicado: (2016)

Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients
por: Han, Myung Hyun, et al.
Publicado: (2019)

Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review
por: Ren, Xiaohan, et al.
Publicado: (2019)

Upfront Stereotactic Radiosurgery for Pineal Parenchymal Tumors in Adults
por: Park, Jong Hoon, et al.
Publicado: (2015)

AL AMYLOIDOSIS UPFRONT TREATMENT AND CURRENT AND FUTURE STUDIES
por: Kastritis, E.
Publicado: (2023)

Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery
por: Chen, Xiaobin, et al.
Publicado: (2019)

Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation
por: Tang, Andy Sing Ong, et al.
Publicado: (2023)

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept
por: Jiang, Rong, et al.
Publicado: (2020)

Comparison of upfront versus deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma receiving systemic therapy: a systematic review and meta-analysis
por: Li, Kun-peng, et al.
Publicado: (2023)

The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
por: He, Libin, et al.
Publicado: (2022)

Ag-Modified Porous Perovskite-Type LaFeO(3) for Efficient Ethanol Detection
por: Yu, Jiejie, et al.
Publicado: (2022)

Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review
por: Wang, Wei, et al.
Publicado: (2023)

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
por: Qin, Chengdong, et al.
Publicado: (2023)

Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer
por: Kuang, Shelley, et al.
Publicado: (2022)

A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
por: Yang, Yuqin, et al.
Publicado: (2022)

A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics
por: Tian, Ningzi, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Preoperative Prediction of Early Recurrence after Upfront Surgery in Pancreatic Ductal Adenocarcinoma by Integrating Deep Learning and Radiological Variables
por: Xiang, Fei, et al.
Publicado: (2023)

LHCb : potential for Kaon physics with a full upfront reconstruction
por: Bettler, Marc Olivier
Publicado: (2016)

Health professionals for global health: include dental personnel upfront!
por: Preet, Raman
Publicado: (2013)

Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
por: Daskalakis, Kosmas, et al.
Publicado: (2018)

Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency
por: Eichinger, Anna, et al.
Publicado: (2021)

Ogilvie’s syndrome—is there a cutoff diameter to proceed with upfront surgery?
por: Joechle, Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aonim7hd7f59ejqfade63iout2